🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian GLP-1 coverage — 12 month update Page 5

Canadian GLP-1 coverage — 12 month update

Dr.SleepRoch Tue, Dec 17, 2024 at 4:46 AM 52 replies 2,746 viewsPage 5 of 11
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Dec 19, 2024 at 6:47 PM#21
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Correct me if the detail matters more than I have assumed.

15 13JenMemphis, pat_auckland, Dr.GastroMayo and 12 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Dec 20, 2024 at 2:33 AM#22
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

16 14MounjBrad, nick_newbie, DadBodDave and 13 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Dec 20, 2024 at 10:19 AM#23
raj_cambridge said:
Keep the original post as written when you update it, and add the correction underneath.

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

17 15MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 14 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Dec 20, 2024 at 6:05 PM#24

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Dec 20, 2024 at 8:05 PM
18 16Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 15 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Dec 21, 2024 at 1:51 AM#25
Dr.MetabolicMD said:
The useful move here is to separate what is established from what is widely repeated.

Second this.

19 17ben_calgary, patPC_UT, Dr.DermMIA and 16 others
Reply Quote Save Share Report
13456711

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register